IE 11 is a very old Browser and it`s not supported on this site

2 Notes to the financial statements

Cash and cash equivalent

CHF 1 000

31.12.2025

31.12.2024

Due from banks

1 621

3 263

Total

1 621

3 263

Other short-term receivables

CHF 1 000

31.12.2025

31.12.2024

Due from group companies

6 077

5 972

Due from third parties

14

33

Total

6 091

6 005

Other short-term receivables from group companies include short-term loans and bore interest of 1.50% in the financial year (2024: 1.50%). The recorded interest is shown in the position «Finance income».

Participations

31.12.2025

31.12.2024

Company

Domicile

Purpose

Currency

Share capital/Nominal capital

Capital

Voting rights

Capital

Voting rights

Bellevue Asset Management AG

Zurich, Switzerland

Asset Management

CHF

1 750 000

100%

100%

100%

100%

Bellevue Asset Management (Deutschland) GmbH

Frankfurt am Main, Germany

Asset Management

EUR

540 000

100%

100%

100%

100%

Bellevue Asset Management (UK) Limited

London, UK

Asset Management

GBP

50 000

100%

100%

100%

100%

Bellevue Asset Management (Singapore) Pte Ltd

Singapore

Distribution

SGD

1 000 000

100%

100%

100%

100%

Asset Management BaB N.V.

Curaçao

Asset Management

USD

6 001

100%

100%

100%

100%

Bellevue Research Inc.

New York, USA

Research

USD

100

100%

100%

100%

100%

Bellevue Private Markets AG

Zurich, Switzerland

Investment Advisor

CHF

1 000 000

100%

100%

100%

100%

Bellevue Komplementär AG

Zurich, Switzerland

Asset Management

CHF

200 000

100%

100%

100%

100%

Bellevue Private Markets Management I S.à.r.l.

Luxembourg

Asset Management

EUR

12 000

100%

100%

100%

100%

adbodmer AG 1)

Zug, Switzerland

Investment Advisor

CHF

100 000

0%

0%

100%

100%

BB Biotech Ventures GP 2)

Guernsey

Investment Advisor

GBP

10 000

0%

0%

100%

100%

1) The company was sold on September 30, 2025.
2) The company was liquidated on August 18, 2025.

As a rule, participations are valued individually. For participations that are already managed and assessed together as an economic business unit within the company, the impairment test of the participations is performed analogously to the IFRS consolidated financial statements at the level of the economic business units.

Impairment of participations

During the financial year, Bellevue Private Markets AG sold its participation in adbodmer AG. As a result of the discontinuation of its operating activities, an impairment of the carrying amount of the participation was required as at December 31, 2025. Consequently, the investment in Bellevue Private Markets AG was impaired by CHF 7.5 mn.

Other short-term liabilities

CHF 1 000

31.12.2025

31.12.2024

Due to group companies

665

Due to third parties

3

32

Total

3

697

Treasury shares

Treasury shares are held directly by the Company. All transactions are carried out at market prices.

Average price in CHF

Number of shares

Balance as of 1.1.2024

305 473

Purchases

17.5685

5 661

Disposals

19.0471

– 134 225

Balance as of 31.12.2024

176 909

Purchases

16.1785

67 289

Disposals

8.4054

– 162 541

Balance as of 31.12.2025

81 657

Disposals and purchases of treasury shares also include any deliveries or returns of treasury shares as part of share-based payments, which are not cash-effective in such cases.